NuSkin Enterprises (NUS)
NYSE Mercado cerrado
Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.
Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.
Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.
The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.
Última actualización
- Capitalización
- 260.72M
- PER
- 4.78
- Precio/FCF
- 6.27
- Precio/Ventas
- 0.18
- Valor de empresa
- 285.66M
- Sector de actividad
- Health Care
- Industria
- Drugs, Drug Proprietaries, and Druggists' Sundries
- Dirección
- 75 WEST CENTER ST, PROVO, UT, 84601
Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%
Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates
Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?
Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?
Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y
Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates
Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings
Philip Morris (PM) Lags Q4 Earnings Estimates
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for
Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why
Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?
Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance
Why Nu Skin (NUS) Could Beat Earnings Estimates Again
e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?
Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings
Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth
Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt
- Capitalización
La capitalización bursátil es el valor total de las acciones de una empresa, calculado multiplicando el precio por el número de acciones en circulación.
- 260.72M
- Valor de empresa
El valor de empresa es el valor total de una compañía, incluyendo capitalización, deuda y efectivo.
- 285.66M
- PER
El PER compara el precio de la acción con el beneficio por acción.
- 4.78
- Precio/Valor contable
El ratio P/B compara el precio de la acción con su valor contable por acción.
- 0.33
- Precio/Ventas
El ratio P/S compara el precio de la acción con los ingresos por acción.
- 0.18
- VE / EBITDA
VE/EBITDA mide el valor de una empresa respecto a su resultado antes de intereses, impuestos, depreciación y amortización.
- 2.17
- VE / Ventas
VE/Ventas mide el valor de una empresa respecto a sus ingresos totales.
- 0.2
- BPA
- 1.12
- Rendimiento por dividendo
El rendimiento por dividendo muestra cuánto paga una empresa en dividendos al año respecto al precio de la acción.
- 6.98%
- Precio/FCF
El ratio precio/flujo de caja libre compara el precio de la acción con el efectivo generado tras gastos e inversiones.
- 6.27
- Precio/Flujo de caja
El ratio P/CF compara el precio de la acción con el flujo de caja de las operaciones.
- 3.43
- Flujo de caja libre
El flujo de caja libre es el efectivo que queda tras cubrir costes operativos y gastos de capital.
- 41.57M
- Rent. sobre fondos propios
El ROE mide la eficacia con la que una empresa utiliza el patrimonio neto para generar beneficios.
- 6.87%
- Rent. sobre activos
El ROA mide la eficacia con la que una empresa utiliza sus activos para generar beneficios.
- 3.96%
- Deuda / Patrimonio
El ratio deuda/patrimonio compara la deuda total con el patrimonio neto.
- 0.28
- Ratio corriente
El ratio corriente mide la capacidad de una empresa para pagar deudas a corto plazo con activos corrientes.
- 2.03
- Prueba ácida
La prueba ácida mide la capacidad de pagar deudas a corto plazo con efectivo y activos fácilmente realizables.
- 1.34
- Efectivo
El ratio de efectivo mide la capacidad de cubrir deudas a corto plazo solo con efectivo y equivalentes.
- 0.77
- Vol. medio
El volumen medio muestra el número promedio de acciones negociadas en los últimos 30 días de bolsa, útil para evaluar la liquidez.
- 649.56K
- Precio de referencia fundamental
El precio de referencia fundamental es el precio de la acción usado al calcular los ratios financieros.
- 5.37
Cuenta de resultados
| Partida | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Ingresos | 320.61M | 370.32M | 364.21M | 386.14M | 364.49M |
| Beneficio bruto | 214.46M | 261.98M | 256.72M | 265.73M | 246.96M |
| Resultado operativo | 4.03M | 23.24M | 21.64M | 30.78M | -9.9M |
| EBITDA operativo | 18.21M | 36.16M | 33.73M | 43.83M | 29.42M |
| Beneficio neto | 1.84M | 14.49M | 17.08M | 21.12M | 107.52M |
| BPA básico | 0.04 | 0.31 | 0.35 | 0.43 | 2.16 |
| BPA diluido | 0.04 | 0.27 | 0.34 | 0.43 | 2.14 |
Balance
| Partida | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Activos totales | 1.38B | 1.41B | 1.42B | 1.44B | 1.39B |
| Pasivos totales | 582.71M | 600.07M | 624.61M | 655.94M | 637.44M |
| Patrimonio neto | 794.09M | 805.24M | 799.8M | 787.75M | 753.97M |
| Efectivo y equivalentes | 198.65M | 238.63M | 251.79M | 264.16M | 203.77M |
| Activos corrientes | 522.89M | 547.7M | 548.14M | 571.55M | 524.86M |
| Pasivos corrientes | 257M | 263.73M | 254.44M | 283.91M | 260.3M |
Flujo de caja
| Partida | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Flujo de caja operativo | -3.92M | 16.62M | 27.48M | 35.8M | 389K |
| Flujo de caja de inversión | -14.29M | -9.76M | -9.92M | 8.79M | 181.54M |
| Flujo de caja de financiación | -20.4M | -18.5M | -26.88M | 9.27M | -166.3M |
| Variación de efectivo | -39.98M | -13.16M | -12.37M | 60.39M | 16.89M |
| Tipo | Informe | Fecha | Enlace |
|---|---|---|---|
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| form 4 | Form 4 — Winett James M | Ver informe | |
| edgar index | S-8 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| form 4 | Form 4 — CAMPBELL DANIEL W | Ver informe | |
| form 4 | Form 4 — CAMPBELL DANIEL W | Ver informe | |
| form 4 | Form 4 — CAMPBELL DANIEL W | Ver informe | |
| form 4 | Form 4 — Thomas Pisano R. | Ver informe | |
| form 4 | Form 4 — Battle Emma S. | Ver informe | |
| form 4 | Form 4 — WOODBURY EDWINA D | Ver informe | |
| form 4 | Form 4 — WOODBURY EDWINA D | Ver informe | |
| form 4 | Form 4 — Zorko Mark A | Ver informe | |
| form 4 | Form 4 — Nathanson Laura | Ver informe | |
| form 4 | Form 4 — Winett James M | Ver informe | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Ver informe | |
| eight k text | 8-K — 8-K | Ver informe | |
| edgar index | SD — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| form 4 | Form 4 — Nathanson Laura | Ver informe | |
| edgar index | 10-Q — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Ver informe | |
| eight k text | 8-K — 8-K | Ver informe | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Ver informe | |
| eight k text | 8-K — 8-K | Ver informe | |
| edgar index | DEF 14A — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | DEFA14A — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | ARS — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 3 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| form 3 | Form 3 — Lantz Chelsea K | Ver informe | |
| edgar index | SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Ver informe | |
| eight k text | 8-K — 8-K | Ver informe | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Ver informe | |
| eight k text | 8-K — 8-K | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| form 4 | Form 4 — WOODBURY EDWINA D | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | Ver informe | |
| eight k text | 8-K — 8-K | Ver informe | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Ver informe | |
| form 4 | Form 4 — Thomas James D | Ver informe | |
| form 4 | Form 4 — Clark Chayce David | Ver informe | |
| form 4 | Form 4 — Hatchett Steven Keith | Ver informe | |
| form 4 | Form 4 — Keisel Justin S | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Ver informe | |
| form 4 | Form 4 — Thomas James D | Ver informe | |
| form 4 | Form 4 — Clark Chayce David | Ver informe | |
| form 4 | Form 4 — Hatchett Steven Keith | Ver informe | |
| form 4 | Form 4 — Keisel Justin S | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | Ver informe | |
| form 4 | Form 4 — NAPIERSKI RYAN S | Ver informe | |
| form 4 | Form 4 — Thomas James D | Ver informe | |
| form 4 | Form 4 — Clark Chayce David | Ver informe |